The human microbiome plays a critical role in our health, influencing everything from disease development to treatment responses.
Roche withdraws EMA expansion application for cancer medicine Gazyvaro after lack of ‘robust’ trial methods
Roche pulled its marketing authorization application with the European Medicines Agency (EMA) earlier this month to expand the label for its cancer medicine Gazyvaro, because